3 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 3, Not yet recruiting 1, Recruiting 1, Terminated 1 |
Follow Livedoid Vasculopathy: new trials by email Literature Review of Livedoid Vasculopathy trials Research Report on Livedoid Vasculopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Emerging Indications for Hyperbaric Oxygen Treatment Hyperbaric oxygen treatment (HBOT), 100% Oxygen - Post-COVID-19 Condition, Ulcerative Colitis | Phase 4 | Not yet recruiting | Jay C. Buckey Jr. | 100 | 2026-11-01 | 2026-09-09 |
| Open Label Treprostinil Raynaud's Study Oral treprostinil (UT-15C) sustained release tablets - Raynaud's Disease, Raynaud Phenomena | Phase 4 | Recruiting | Brigham and Women's Hospital | 30 | 2025-10-15 | 2026-03-24 |
| Botulinum Toxin in Raynaud's Phenomenon Botulinum toxin - Raynaud Phenomenon | Phase 4 | Completed | Emory University | 24 | 2022-02-10 | 2026-07-29 |
| The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's Phenomenon AbobotulinumtoxinA, Saline solution - Raynaud Phenomenon | Phase 4 | Terminated | University of Central Florida | 3 | 2018-08-31 | 2021-06-30 |
| Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon Pletal - Raynaud's Disease | Phase 4 | Completed | Otsuka America Pharmaceutical | 75 | 2001-10-01 | 2005-07-19 |
| Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon Pletal - Raynaud's Disease | Phase 4 | Completed | Otsuka America Pharmaceutical | 75 | 2001-10-01 | 2005-07-19 |
Raynaud Disease (6) · Calciphylaxis (1) · Colitis, Ulcerative (1) · Connective Tissue Diseases (1) · Craniocerebral Trauma (1) · Crohn Disease (1) · Enterocolitis, Pseudomembranous (1) · Epidermolysis Bullosa (1) · Frostbite (1) · Graft vs Host Disease (1) · Hypospadias (1) · Invasive Fungal Infections (1) · Mixed Connective Tissue Disease (1) · Multiple Sclerosis (1) · Myositis, Inclusion Body (1)
Cardiovascular Diseases (6) · Embolism and Thrombosis (6) · Peripheral Vascular Diseases (6) · Skin Diseases (6) · Skin Diseases, Vascular (6) · Skin and Connective Tissue Diseases (6) · Thrombosis (6) · Vascular Diseases (6) · Arterial Occlusive Diseases (1) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Bone Diseases (1)
Cilostazol (2) · Botulinum Toxins (1) · Oxygen (1) · Saline Solution (1) · abobotulinumtoxinA (1) · treprostinil (1)
Otsuka America Pharmaceutical (2) · Brigham and Women's Hospital (1) · Emory University (1) · Jay C. Buckey Jr. (1) · University of Central Florida (1)
United States (5)
Aaron B Waxman, MD, PhD (1) · Jay Buckey (1) · Paul A Ghareeb, MD (1)